Related Experiment Video

Updated: May 30, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Current and planned multicenter trials for patients with primary or metastatic melanoma

Vernon K Sondak1, Dale Han, Jeremiah Deneve

  • 1The Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA. vernon.sondak@moffitt.org

Journal of Surgical Oncology
|August 23, 2011
PubMed

Insights

Multicenter clinical trials are advancing malignant melanoma care, improving patient outcomes for localized and advanced disease. Ongoing trials continue to define the latest surgical and medical management standards for this cancer.

Area of Science:

  • Oncology
  • Clinical Trials
  • Dermatology

Background:

  • Multicenter clinical trials have significantly advanced the standard of care for malignant melanoma.
  • These trials have introduced novel therapies, enhancing outcomes for patients with both loco-regional and distant melanoma.
  • Despite progress, critical questions persist in melanoma management.

Purpose of the Study:

  • To review current and planned multicenter clinical trials in malignant melanoma.
  • To highlight how these trials are shaping contemporary melanoma management strategies.
  • To provide an overview of the evolving landscape of melanoma research.

Main Methods:

  • Literature review of ongoing and planned multicenter clinical trials.
  • Synthesis of trial objectives and their implications for patient care.
  • Analysis of how trial results contribute to established standards.

Main Results:

  • Established new standards of care in surgical and medical management.
  • Facilitated testing of novel therapeutic agents.
  • Demonstrated improved patient outcomes in loco-regional and distant disease settings.

Conclusions:

  • Multicenter trials are pivotal in defining current and future melanoma management.
  • Ongoing research continues to address unmet needs in treating malignant melanoma.
  • The collaborative nature of these trials accelerates progress in oncology.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.